Tuesday, June 10, 2014

Our Brains, Ourselves

On April 2, 2014, United States President Barack Obama announced the Brain Research through Advancing Innovative Neurotechnologies ("BRAIN") Initiative, whose mission is to “accelerate the development and application of new technologies that will enable researchers to produce dynamic pictures of the brain that show how individual brain cells and complex neural circuits interact at the speed of thought.”  The U.S. National Institutes of Health ("NIH") will help lead this ambitious effort.  To this end, its (BRAIN) Working Group released a report on June 5, 2014, entitled BRAIN 2025: A Scientific Vision.  This report begins with a bold assertion unlikely to attract universal agreement among neurobiologists and other scientists who study the complex relationships between brain, cognition, and behavior:
The human brain is the source of our thoughts, emotions, perceptions, actions, and memories;  it confers on us the abilities that make us human, while simultaneously making each of us unique. Over recent years, neuroscience has advanced to the level that we can envision a comprehensive understanding of the brain in action, spanning molecules, cells, circuits, systems, and behavior.
The report ends in a similarly ambitious tone:
The BRAIN Initiative is a challenge and an opportunity to solve a central mystery—how organized circuits of cells interact dynamically to produce behavior and cognition, the essence of our mental lives. The answers to that mystery will not come easily. But until we start, the progress we desire will always be distant. The time to start is now.
Hoping to replicate the successes of the Human Genome Project, President Obama has thrown down the gauntlet to neurobiologists.  Research into the brain is likely to yield many benefits to society.  However, just as complete knowledge of the nucleotide sequence of our genomes is unlikely to offer complete understanding of our genetics, neither is comprehensive mapping of our neural circuits likely to reveal the "essence of our mental lives."  A better scientific description of the brain will certainly shed valuable light on behavior.  However, understanding behavior is unlikely to be as easy as characterizing neurons and neural circuits.   

Friday, June 6, 2014

Two New Biolaw Journals

The field of biolaw is taking wing in many directions.  A signal achievement has been the recognition of an official Biolaw Section at the American Association of Law Schools.  However, biolaw scholarship has lacked a home, instead being scattered throughout numerous unrelated publications.  That may begin to change with the creation of two new academic journals dedicated to biolaw.  The Journal of Law and the Biosciences describes its mission as follows:
The Journal of Law and the Biosciences (JLB) is the first fully Open Access peer-reviewed legal journal focused on the advances at the intersection of law and the biosciences. A co-venture between Duke University, Harvard University Law School, and Stanford University, and published by Oxford University Press, this open access, online, and interdisciplinary academic journal publishes cutting-edge scholarship in this important new field. The Journal contains original and response articles, essays, and commentaries on a wide range of topics, including bioethics, neuroethics, genetics, reproductive technologies, stem cells, enhancement, patent law, and food and drug regulation.
Across the Pond, the BioLaw Journal/Rivista di BioDiritto has announced a similar focus:
BioLaw Journal – Rivista di BioDiritto is a peer reviewed, online law journal focusing on the relationships between law and life sciences under a comparative perspective. According to its interdisciplinary nature, the Journal hosts contributions in the fields of law, life sciences and bioethics.
The Journal presents articles, commentaries and book reviews which provide an innovative and original source of reference for academics, lawyers, legal and medical practitioners, law students, and anyone interested in national, European and international biolaw.
These two new journals are welcome additions to the burgeoning field of biolaw.

Thursday, May 29, 2014

Unforgettable Rights

In Google Inc. v. Mario Costeja González, the European Court of Justice ("ECJ") ruled, on May 13, 2014, that, under certain circumstances, European Union ("EU") citizens possess a right not to have embarrassing information about them linked to by search engines.  Here is how the ECJ described the basic facts of the case:
On 5 March 2010, Mr Costeja González, a Spanish national resident in Spain, lodged with the AEPD a complaint against La Vanguardia Ediciones SL, which publishes a daily newspaper with a large circulation, in particular in Catalonia (Spain) (‘La Vanguardia’), and against Google Spain and Google Inc. The complaint was based on the fact that, when an internet user entered Mr Costeja González’s name in the search engine of the Google group (‘Google Search’), he would obtain links to two pages of La Vanguardia’s newspaper, of 19 January and 9 March 1998 respectively, on which an announcement mentioning Mr Costeja González’s name appeared for a real-estate auction connected with attachment proceedings for the recovery of social security debts. 
By that complaint, Mr Costeja González requested, first, that La Vanguardia be required either to remove or alter those pages so that the personal data relating to him no longer appeared or to use certain tools made available by search engines in order to protect the data. Second, he requested that Google Spain or Google Inc. be required to remove or conceal the personal data relating to him so that they ceased to be included in the search results and no longer appeared in the links to La Vanguardia. Mr Costeja González stated in this context that the attachment proceedings concerning him had been fully resolved for a number of years and that reference to them was now entirely irrelevant.
The ECJ decided that EU citizens, such as Mario Costeja González, have a limited right to be forgotten on the internet.

However, this case has now been appealed to a much higher court:  Last Week Tonight With John Oliver.  Here is Justice Oliver's verdict on the right to be forgotten:
Despite a brave attempt by the ECJ to erase internet memory, it is likely that John Oliver will have the last laugh.

Friday, May 16, 2014

An Uncommonly Good Knowledge Commons

The Medical User Innovation and Medical Knowledge Commons Workshop is taking place from May 15-17, 2014, at the Engelberg Center on Innovation Law & Policy at the New York University School of Law.  The research projects presented at the workshop have been uniformly fascinating, ranging from innovation in therapies for rare diseases to a brain science information commons to correlates of success in medical device entrepreneurship.  The project I presented is entitled "A Highly Uncommon Commons:  The Evolution of Synthetic Biology Institutions and Democratized Innovation in Medicine."  If the research presented at this workshop results in an edited volume, that book will be a signal contribution to our understanding of innovation.

Friday, May 9, 2014

Synthetic Biology Governance

Bryn Nelson has published an excellent article in the leading science journal, Nature, on some of the legal, ethical, economic, and democratic issues raised by patent and open source models of innovation in synthetic biology.  Entitled Synthetic Biology:  Cultural Divide, the article provides a vivid snapshot of the current state of synthetic biology, a field that is at once exploding in influence and bedeviled with uncertainty about how its DNA building blocks will, and should, be governed.  I was honored that Nelson included me among the synthetic biology scholars he interviewed for his article.  I have previously published several articles on synthetic biology, including Synthesizing Law for Synthetic Biology (2010), DNA Copyright (2011) and Planted Obsolescence: Synagriculture and the Law (2012).  In addition, I was commissioned by the National Academies (with coauthor Dr. Linda Kahl) to write a report, entitled Synthetic Biology Standards and Intellectual Property, that I presented at the National Academies in Washington, D.C., on November 4, 2013.  An article based on this report was recently published as Bringing Standards to Life: Synthetic Biology Standards and Intellectual Property (2014).  The evolution of synthetic biology continues to be fascinating.

Tuesday, May 6, 2014

Hot Science And Heated Policy

One of the most interesting classes I ever took was offered by the John F. Kennedy School of Government and trained students to apply insights from science to the making of sound public policy.  My two professors for the class were William C. Clark and John P. Holdren.  Together they were dynamite.

Holdren has been the Director of the Office of Science and Technology Policy for President Barack Obama since 2009.  One of the projects he has overseen is the third National Climate Assessment (NAC), which was published on May 6, 2014.  Here is an overview of the third NAC by Holdren.

The third NAC is a treasure trove of information about how climate change may affect the United States, in general, and each region of the country, in particular.  One conclusion of this assessment is quite simple:  it's neither the heat nor the humidity, but both simultaneously.

Tuesday, April 29, 2014

Octane Fitness v. Icon Health & Fitness

On April 29, 2014, the United States Supreme Court issued a decision that eases the awarding of attorneys fees to penalize patently bad litigation behavior. Here is how the Supremes describe the controversy in Octane Fitness v. Icon Health & Fitness in the opinion Syllabus:
The Patent Act’s fee-shifting provision authorizes district courts to award attorney’s fees to prevailing parties in “exceptional cases.” 35 U.S.C. §285. In Brooks Furniture Mfg., Inc. v. Dutailier Int’l, Inc., 393 F. 3d 1378, 1381, the Federal Circuit defined an “exceptional case” as one which either involves “material inappropriate conduct” or is both “objectively baseless” and “brought in subjective bad faith.” Brooks Furniture also requires that parties establish the “exceptional” nature of a case by “clear and convincing evidence.” Id., at 1382. Respondent ICON Health & Fitness, Inc., sued petitioner Octane Fitness, LLC, for patent infringement. The District Court granted summary judgment to Octane. Octane then moved for attorney’s fees under §285. The District Court denied the motion under the Brooks Furniture framework, finding ICON’s claim to be neither objectively baseless nor brought in subjective bad faith. The Federal Circuit affirmed.
The Supremes held "The Federal Circuit’s formulation...overly rigid."  They clarified that
a district court may award fees in the rare case in which a party’s unreasonable conduct — while not necessarily independently sanctionable — is nonetheless so “exceptional” as to justify an award of fees.
In addition, the Court rejected
the Federal Circuit’s requirement that patent litigants establish their entitlement to fees under §285 by “clear and convincing evidence."
Instead, the Supremes explained that
[s]ection 285 demands a simple discretionary inquiry; it imposes no specific evidentiary burden, much less such a high one.
This decision rebalances the power to decide what constitutes an "exceptional" case away from the Federal Circuit, restoring considerable discretion to federal district courts.

Friday, April 25, 2014

Seeds Of Change At Cornell

On April 25, 2014, the Department of Plant Breeding and Genetics at Cornell University held the 3rd Annual Plant Breeding Symposium, ("Breeding Innovations & Policy:  Considering Diverse Stakeholders") cosponsored by SYNAPSIS (the Cornell Plant Breeding & Genetics Graduate Student Assocation) and DuPont Pioneer.  I was honored to be invited to speak at the conference.  Here is the abstract of my speech, entitled "Biology, Law, and Democratization as Seeds of Change for Agricultural Innovation":
The past decade has witnessed sea changes in both the science and law of agricultural biotechnology.  Accelerating growth in the power and precision of molecular biology, genomics, and bioinformatics offer myriad new tools for improvements in crop characteristics and cultivation methods. More fundamentally, the new field of synthetic biology represents a paradigm shift in how and by whom agricultural biology is to done. The law has evolved in parallel with, and often in reaction to, these scientific changes. The United States Supreme Court has weakened or ended the patenteligibility of isolated genomic DNA, products of physiology, biochemical assay methods, and process inventions involving steps dependent on human thought. Improved methods for measuring patent importance promise to demystify the value and liability risks of agricultural patent portfolios. Most disruptively, open, user, and collaborative innovation is vastly increasing participation in biotechnology. The result of new biotechnologies, altered legal landscapes, and changing patterns of participation is the transformation and democratization of agricultural innovation.
The great unresolved tension between open access, traditional, indigenous, and intellectual property regimes for governing rights to plant breeds and seeds was the dominant theme.  The range of views represented in the speakers' presentations resulted in a wonderful discussion of plant breeding and agricultural biotechnology.  Though we may not have reached intellectual synthesis of the level imagined by Titania, who says, in A Midsummer Night's Dream, "So doth the woodbine the sweet honeysuckle gently entwine," we did grapple with important issues in this vital field in the midst of the finest plant breeding and genetics scholars.

Tuesday, April 22, 2014

Unconventional Conventional

Over the past two weeks, students in my new "Biolaw" class have been presenting their own term projects.  These have run a wide gamut through the subject matter of biolaw, from blood donation to gender identity, patents on humans to management of the Antarctic, and behavioral ecology of criminal behavior to accounting for ecosystem services.

One presentation surprised me the most through its casual, though accurate, use of a word whose meaning has clearly been transformed over the past decade.  The subject was the role of law in settling conflicts between farmers growing genetically-engineered crops and those attempting to cultivate organic crops.  The presenter described GM-crops as "conventional."

When I first heard the descriptor "conventional," my mind reacted against the usage, initially deeming it inaccurate.  But, after I had let the meaning sink in for a few seconds, I realized that the world had linguistically shifted beneath my feet.  Genetically-engineered crops are now so typical as to be banal.  "Traditional" crops of the sorts favored by organic farmers are now strange and exotic.  Convention has rendered GM-agriculture conventional.